HomeNewsTrendsFeaturesSomeone do the costing

Someone do the costing

These are somber times, yes, but also a period to set the frivolous and the fancy apart from bare necessities.

May 30, 2020 / 06:47 IST
Story continues below Advertisement

So we sit like Scrooge counting all our money these days. We haven’t done this in a long while; add up all our assets and delete all our liabilities. Now we know how much we have in savings, down to the smallest change. We never had to do this before, see what stood between us and total starvation. The virus has brought money, or a lack of it, sharply into focus. Are we in the red or in the black or somewhere so in the middle a new colour was created just for us?

We can barely recognise ourselves in old selfies; laughing drunkenly in some bizarre new bar with people we don’t text anymore. In our memories from this year itself we were different people, people who vaguely knew they were financially comfy, without having to count every fixed deposit.

Story continues below Advertisement

The good news is our expenses are down. No parties to be hosted, no foreign holidays, not even a birthday gift to be purchased. We realise how frugal our meals are, how affordable, especially when lobster and avocado go missing from the market shelves and our diet. We won’t have to eat our family members out of sheer hunger in the foreseeable future.

The bad news is that we miss spending our money. You know, that metal moth we saw in a back-alley shop on one of our rural getaways; how we loved buying it and hanging it on our garden wall, and casually bringing up the story of where we saw it first. If making money was a joyless affair, spending it was always a thrill. We don’t get the same pleasure out of shopping today; the virus has been a buzz-kill. We do wander online, adding to the cart, but a little voice in our heads nags us constantly: ‘Do we need this, do we really need this?’

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show